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Identification of miR-145 as a Key Regulator of
the Pigmentary Process
Peter Dynoodt1, Pieter Mestdagh2, Gert Van Peer2, Jo Vandesompele2, Karen Goossens3, Luc J. Peelman3,
Barbara Geusens1, Reinhart M. Speeckaert1, Jo L.W. Lambert1 and Mireille J.L. Van Gele1
The current treatments for hyperpigmentation are often associated with a lack of efficacy and adverse side
effects. We hypothesized that microRNA (miRNA)-based treatments may offer an attractive alternative by
specifically targeting key genes in melanogenesis. The aim of this study was to identify miRNAs interfering with
the pigmentary process and to assess their functional role. miRNA profiling was performed on mouse
melanocytes after three consecutive treatments involving forskolin and solar-simulated UV (ssUV) irradiation.
Sixteen miRNAs were identified as differentially expressed in treated melan-a cells versus untreated cells.
Remarkably, a 15-fold downregulation of miR-145 was detected. Overexpression or downregulation of miR-145
in melan-a cells revealed reduced or increased expression of Sox9, Mitf, Tyr, Trp1, Myo5a, Rab27a, and Fscn1,
respectively. Moreover, a luciferase reporter assay demonstrated direct targeting of Myo5a by miR-145 in mouse
and human melanocytes. Immunofluorescence tagging of melanosomes in miR-145-transfected human
melanocytes displayed perinuclear accumulation of melanosomes with additional hypopigmentation of
harvested cell pellets. In conclusion, this study has established an miRNA signature associated with forskolin
and ssUV treatment. The significant down- or upregulation of major pigmentation genes, after modulating miR-
145 expression, suggests a key role for miR-145 in regulating melanogenesis.
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INTRODUCTION
Skin pigmentation is a complex multistep process leading to
the distribution of melanin particles throughout the different
layers of the epidermis. This provides a photoprotective
barrier against UVR as melanin acts as a UV absorbant and
exerts antioxidative and radical scavenging activities (Bren-
ner and Hearing, 2008; Yamaguchi and Hearing, 2009).
Melanogenesis takes place in specific organelles, called
melanosomes, which are produced in the melanocytes of the
skin (Raposo and Marks, 2007). During their maturation,
melanosomes are transported from the perinuclear region
into the dendritic tips of melanocytes and are subsequently
transferred to surrounding keratinocytes.
Several key proteins involved in melanogenesis and
melanosome transport have been identified. Tyrosinase
(TYR) is the rate-limiting enzyme of melanin synthesis and
is induced after UVR as part of the tanning response. TYR
cooperates with TYR-related protein 1 (TYRP1) and dopa-
chrome tautomerase to synthesize the two main types of
melanin: eumelanin and pheomelanin (Costin et al., 2005).
TYR defects, caused by mutations, are known to cause
albinism in humans (Saxena and Verma, 2010). Another
critical factor in melanin production is micropthalmia-
associated transcription factor (MITF), which, besides reg-
ulating survival and proliferation of melanocytes, induces the
expression of several pigmentation genes (e.g., TYR and
TYRP1) (Vachtenheim and Borovansky, 2010; Levy and
Fisher, 2011). The MITF promotor is regulated by various
other transcription factors, including sex-determining
region Y-box (SOX9) (Passeron et al., 2007; Wan et al.,
2011). Mature melanosomes make short-range movements
along actin filaments through the tripartite protein complex
consisting of Rab27a-myosin Va-melanophilin. Mutations in
any of these pigment transport genes lead to a dysfunction of
the tripartite complex, causing accumulation of melanosomes
in the perinuclear regions of these mutant melanocytes,
because of disruption of their anchoring onto the cell
periphery (Wu et al., 2002; Westbroek et al., 2003).
Mutations in myosin VA (MYO5A), RAB27A, and melano-
philin (MLPH) are a cause of different forms of Griscelli
syndrome in humans (GS type I, II, and III, respectively).
These patients are characterized by mild hypopigmentation
of the skin and hair (Van Gele et al., 2009). A blockade of
the intracellular transport of melanosomes can be mimicked
in vitro by RNA interference-induced silencing of the exon
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F isoforms of MYO5A (Van Gele et al., 2008). However, as
more than 150 genes have been identified to affect
pigmentation, sole inhibition of one particular gene might
not be the most effective strategy to induce hypopigmentation
in vivo (Bennett and Lamoreux, 2003; Chi et al., 2006).
Dysregulation of multiple genes involved in melanosome
synthesis and transport, e.g., under the control of one or
multiple microRNAs (miRNAs), might offer a more potent
approach.
miRNAs are single-stranded noncoding RNA molecules
that span over 18–24 nucleotides. They form a large family of
regulatory molecules found in all multicellular organisms and
are able to inhibit the expression of protein-coding genes.
In humans, most miRNAs imperfectly base pair with the
30-untranslated region (30UTR) of target messenger RNAs
(mRNAs) and inhibit subsequent protein synthesis by either
repressing translation or promoting mRNA degradation.
miRNAs have proven to be able to regulate multiple genes
involved in the same molecular pathway. This enables a
single miRNA to have critical roles in a variety of biological
processes such as cell proliferation, differentiation, apoptosis,
and carcinogenesis (He and Hannon, 2004; Iorio and Croce,
2009; Huang et al., 2010; Tsang et al., 2010; Gandellini
et al., 2011). In addition, miRNAs have been associated with
different cellular stress responses such as oxidative stress,
nutrient deprivation, DNA damage, and oncogenic stress
(Leung and Sharp, 2007, 2010).
UVR is the major environmental inducing factor of the
melanogenesis process upregulating a network of genes
involved in the pigmentation process. Interestingly, plant
research reveals that expression patterns of miRNAs change
in response to UVB radiation (Zhou et al., 2007; Jia et al.,
2009). In addition, irradiation of NIH3T3 cells with a low
dose of UVB also results in robust changes of their miRNA
expression pattern, in a time-dependent manner (Guo et al.,
2009). Identification of miRNAs regulated by UV irradiation,
followed by the determination of their target genes and
corresponding gene networks, will lead to more insights in
the regulation of UV signaling pathways.
In this study, we explore the miRNA expression profiles of
melan-a cells responding to the treatment of solar-simulated
UV (ssUV) and forskolin. Sixteen differentially expressed
miRNAs could be identified in treated melan-a cells versus
untreated cells. One of these miRNAs, miR-145, was 15-fold
downregulated. This led us to functionally characterize miR-
145 and investigate its effect on the expression of genes
influencing melanogenesis and melanosome transport in
pigment cells.
RESULTS
Identification of miRNAs involved in the pigmentary process
To adequately mimic the physiological pigmentation process
and to identify the miRNAs involved, it is necessary to
establish a robust in vitro model system using ssUV and
forskolin treatments on pigment cells. The responses are
expected to stimulate the production, processing, and
transport of melanosomes, which all have an essential role
during melanogenesis. A melan-a mouse cell line (Palmisano
et al., 2008) representing normal functioning pigment-
producing melanocytes was chosen. Compared with human
primary melanocytes, this cell line is known to be signifi-
cantly more responsive to physiological pigmentation factors,
such as a-melanocyte-stimulating hormone and UVR (Lei
et al., 2002; Yoon and Hearing, 2003). In addition, by using
melan-a cells, a less complex in vitro cell culture model was
introduced, in contrast to human primary melanocytes that
are typically characterized by donor-specific variability. The
treatment protocol is schematically depicted in Figure 1a.
Three treatments were performed on melan-a cells consisting
of a low ssUV dose (60 mJ cm2) and addition of forskolin
(20 mM), a known stimulator of the cAMP pathway. These
treatments consequently induced pigmentation, whereby the
phenotypic appearance of the cells could be monitored by
bright-field microscopy. Increased proliferation of the treated
cells with additional production of melanin, including an
increased processing/movement of the melanosomes toward
the periphery of the melanocytes and into the dendritic tips,
was observed (data not shown).
To confirm these observations, quantification of mRNA
expression levels of a number of key genes involved in the
pigmentation process was determined by real-time quantita-
tive PCR (RT-qPCR) (Figure 1b). A marked upregulation of
the key pigmentation genes was observed, when comparing
treated versus control samples. Upregulation was 2.2
(±SEM¼0.2)-fold for Mitf, 3.4 (±SEM¼0.2)-fold for Sox9,
1.7 (±SEM¼0.2)-fold for Trp1, and 3.3 (±SEM¼ 0.2)-fold
Treatments
Days 0
4
3.5
3
2.5
2
1.5
1
0.5
0
Mitf Myo5a Rab27a Sox9 Trp1 Tyr
1 2 3 4
Treatment = ssUV (60 mJ cm–2) + forskolin (20 µM)
*
**
** **
*
**
Control
Treated
5 6
Plate
melan-a
Fo
ld
 c
ha
ng
es
Treatment 1 Treatment 2 Treatment 3 Harvest
1.7×105/P60
Figure 1. Experimental setup and induction of pigmentation genes at the
messenger RNA (mRNA) level. (a) Schematic representation of the treatment
protocol. (b) The mRNA expression levels of several pigmentation genes (Mitf,
Myo5a, Rab27a, Sox 9, Trp1, and tyrosinase (Tyr)) were determined by real-
time quantitative PCR 24 hours after the last treatment of melan-a cells.
The graph shows normalized gene expression levels (fold changes) of all
examined genes in the melan-a-treated cells (gray bars) versus nontreated
cells (controls, black bars). The mRNA expression level of each gene was
significantly increased after treatment. The mean (±SEM) of three
independent experiments is shown. All values were compared with their
control counterpart using an unpaired t-test. P-values are indicated with
* (o0.05) or ** (o0.001). ssUV, solar-simulated UV.
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for Tyr. Two genes,Myo5a and Rab27a, which, together with
Mlph, form a tripartite complex, were upregulated by 2.8
(±SEM¼0.2)- and 3.5 (±SEM¼ 0.2)-fold, respectively. On
the basis of these data, we conclude that a reliable and
reproducible pigmentation assay was obtained.
Subsequently, the expression of 540 miRNAs for each
triplicate control sample versus each triplicate treated sample
was profiled. The cutoff value for considering a miRNA as
deregulated was set at 1.5-fold (mean value) between treated
and control samples. This filtering resulted in a miRNA
signature for our pigmentation assay, identifying 16 differen-
tially expressed miRNAs. The majority of these miRNAs were
uniformly downregulated in treated samples compared with
control counterparts. These include miR-125b, miR-139-5p,
miR-145, miR-155, miR-193*, miR-206, miR-218, miR-221,
miR-222, miR-28, miR-335*, miR-365, and miR-455. In
contrast, three miRNAs were upregulated. These included
miR-130b, miR-182, and miR-9. We decided to focus on
miR-145, considering that treated samples displayed on
average a 15-fold downregulation in comparison with their
controls (Supplementary Table S1 online).
Modulation of miR-145 expression influences key pigmentation
genes
To assess the role of miR-145 in the pigmentation process,
overexpression with the aid of pre-miRs (mimics) has been
performed in melan-a cells. Three consecutive post-transfec-
tion (PT) time points (24, 48, and 72 hours) were monitored.
Overexpression of miR-145 was confirmed by RT-qPCR
(Figure 2a). In addition, the expression levels of several genes
involved during the pigmentation process were also deter-
mined. These genes have been subdivided into genes
involved in the onset of the pigmentary process (Sox 9, Mitf,
Tyr, and Trp1), and genes involved in the correct processing
and transfer of melanosomes to the periphery (Fscn1, Myo5a,
and Rab27a). When observing genes involved in the
initiation of melanogenesis, a knockdown effect was ob-
served 72 hours PT. Sox9 showed a 70% (±SEM¼4), Mitf a
60% (±SEM¼3%), Tyr a 63% (±SEM¼7%), and Trp1 a
50% (±SEM¼6%) knockdown of their gene expressions
(Figure 2b). With regard to genes involved in processes
situated at the periphery of the melanocytes, a sharp decline
in Fscn1 (84% (±SEM¼ 15%)) as well as Myo5a (62%
(±SEM¼7%)) gene expressions was detected 24 hours PT.
This knockdown persisted after 72 hours, with Fscn1 showing
a 67% decline (±SEM¼7%) and Myo5a an 81%
(±SEM¼2%) decline. Rab27a showed a similar expression
pattern but evolved in a time-dependent manner, finally
resulting in a 51% (±SEM¼3%) knockdown after 72 hours
(Figure 2c).
The effect of miR-145 overexpression on the protein levels
of several pigmentation genes was investigated by western
blotting. The experiments were performed in triplicate by
transfecting pre-miR-145 in melan-a cells compared with
scrambled negative controls. Protein samples were collected
72 hours PT. Western blot analysis correlated with the qPCR
data, demonstrating knockdown of protein levels of Myo5a
by 61% (±SEM¼4%), Rab27a by 25% (±SEM¼1%), Tyr by
65% (±SEM¼ 5%), and Fscn1 by 20% (±SEM¼ 4%) (Figure
2d). In addition, downregulation of miR-145 using an anti-
miR resulted in upregulation of Sox9 (41% (±SEM¼ 1%)),
Mitf (60% (±SEM¼ 22%)), Tyr (143% (± SEM¼ 13%)),
Fscn1 (87% (± SEM¼ 14%)), Myo5a (78% (± SEM¼
14%)), and Rab27a (57% (± SEM¼ 8%)) gene expression
levels, 48 hours PT (Supplementary Figure S1 online). These
data provide evidence that miR-145 is a physiological
regulator of Myo5a and other genes involved in the
pigmentation process.
miR-145 targets a binding site of Myosin Va
To identify possible relevant target genes of miR-145, we
initially used the online miRNA target prediction software,
TargetScan (Lewis et al., 2005). This target prediction
database generated a list of candidate transcripts with
putative miR-145-binding sites. We focused on target genes
involved during the pigmentary process/melanogenesis.
Myosin Va was identified as a potentially interesting target.
For the mouse, TargetScan database lists two proximal
binding regions on the 30UTR. The first predicted target site
for miR-145 pairing on Myo5a is located at position 123–130
and is a highly conserved 8-mer binding site. The second is
located at position 456–462 of Myo5a 30UTR and contains
a potential 7-mer binding site for the mature miR-145. To
address Myo5a as a direct target of miR-145, a luciferase
target reporter assay was designed for the two potential
Myo5a-binding sites located at the proximal region of 30UTR.
The luciferase reporter assay for mouse Myo5a confirmed an
actual target site for miR-145. Luciferase activity was
significantly decreased (32% decrease, ±4% SEM) at one
of the two predicted sites (positions 123–130) (Figure 3a). This
effect was not observed when the putative miR-145-binding
region was replaced with a scrambled sequence (rescue
experiment). The sequences of the constructs used during the
luciferase reporter assays described above are shown in
Supplementary Table S2 online. The second predicted
binding site for Myo5a did not affect luciferase activity of
the reporter assay (data not shown).
Interestingly, human myosin VA contains three putative
miRNA-binding sites for hsa-miR145, whereby the first one is
highly conserved between mammals. To investigate whether
miR-145 directly binds to the 30UTR of human MYO5A,
we created a wild-type 30UTR MYO5A luciferase reporter
construct containing all three putative miRNA-binding sites.
Reporter constructs containing single-site mutations for each
individual binding sites of miR-145 (Mut1, Mut2, or Mut3)
were also engineered by introducing 4-bp mutations on each
of the three miRNA seed regions separately located on the
30UTR of MYO5A (Supplementary Figure S2 online). Each
construct was used in a luciferase reporter assay in
combination with either a pre-miR-145 or a validated pre-
miR negative control. The pre-miR-145 significantly reduced
the luciferase activities of the wild-type MYO5A by 34%
(±7% SEM), compared with the negative control (Figure 3b).
In addition, the reporter construct (Mut1) containing muta-
tions in the seed region of binding site 1 (position 129–136 of
MYO5A 30UTR) rescued the MYO5A reporter repression,
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indicating that the first binding site contains an active binding
region for miR-145 on MYO5A. Mutant reporters for binding
site 2 or 3 did not result in a significant rescue of the MYO5A
reporter repression (data not shown).
Overexpression of miR-145 inhibits melanosome transport and
induces depigmentation
To study the effect of miR-145 in melan-a cells, immuno-
fluorescent staining using an antibody against melanosomes
(HMB45) and Myo5a was performed. The cells were fixed 5
days PT and fluorescence images were taken. A clear image
of perinuclear accumulation of melanosomes was observed
in melan-a cells after transfection with miR-145, in contrast
to the distribution of melanosomes at the dendritic tips in
non-transfected melanocytes (Figure 4a, left panel). Phalloi-
din staining showed an intact actin cytoskeleton (Figure 4a,
right panel).
As influencing pigmentation in human melanocytes or
skin, by modulating the expression of miR-145, would be of
potential high interest as a dermatological or therapeutical
application, we decided to investigate the role of miR-145
in human primary melanocytes. Overexpression of miR-145
in human primary melanocytes (Supplementary Figure 3Sa
online) resulted in a time-dependent decrease of the same
pigmentation genes studied in melan-a cells (Supplementary
Figure 3Sb and c online). For protein analysis, we focused on
MYO5A and were able to show that the protein level of
MYO5A (58% decrease, ± 3% SEM) was also decreased in
pre-miR-145-transfected human pigment cells compared
with control cells (Supplementary Figure 3Sd online).
Interestingly, immunostaining of the melanosomes in
transfected human melanocytes showed retention of the
melanosomes around the nucleus (Figure 4b), similarly seen
in melan-a-transfected cells. In addition, equal amount of cell
pellets harvested from pre-miR-145-transfected human mel-
anocytes displayed a hypopigmentation effect (reduction of
54%) compared with their control counterparts. This light-
ening effect increased in a time-dependent manner and
started 4 to 5 days PT (Figure 4c).
By performing a successful in vitro rescue experiment
(cotransfection of anti-miR-145 and small interfering RNA
(siRNA) against MYO5A versus siMYO5A, followed by
immunohistochemical staining of fixed cells), we were able
to provide compelling evidence, next to our luciferase
reporter assay, that MYO5A is a target of miR-145 in human
melanocytes. The perinuclear effect caused by siMYO5A was
restored to wild type after cotransfecton with an anti-miR-
145, owing to an enhanced endogenous expression of
MYO5A (Supplementary Figure S4 online).
DISCUSSION
The mechanisms by which specific miRNAs may transcrip-
tionally regulate the pigmentation pathway have remained
largely elusive. To our knowledge, only two miRNAs have
been described to be involved in the pigmentation process.
Wu et al. (2008) designed a miR-434-5p-targeting TYR in
human and mouse melanocytes, and Zhu et al. (2010)
considered miR-25-targeting MITF as a regulator of pigmen-
tation in Alpaca melanocytes. In this study, a novel miRNA
signature associated with ssUV and forskolin has been
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Figure 2. Effect of miR-145 overexpression on the expression of genes involved in the pigmentary process.Melan-a cells were transfected with 50 nM pre-miR-
145 or negative controls. The relative expression levels of miR-145 and several pigmentation genes were determined by real-time quantitative PCR. The mean
ratio of the treated samples versus the mean ratio of negative controls was plotted for miR-145 and each analyzed gene at different time points. A clear
overexpression of miR-145 was observed (a). A time-dependent decrease in gene expression levels (ratio o1) was observed for genes involved at the onset of
pigmentation (Sox9,Mitf, tyrosinase (Tyr), and Trp1) (b) and for genes involved in the transport and transfer of melanosomes to the cell periphery (Fscn1,Myo5a,
and Rab27a) (c). The ratio (treated vs. control) is shown as the mean (±SEM) of three independent experiments. P-values were determined with an unpaired t-
test and are indicated with * (o0.05) or ** (o0.001) (d). Western blots and densitometry values (n¼ 3, ±SEM) demonstrating downregulation of Myo5a,
Rab27a, Tyr, and Fscn1 of pre-miR-145-transfected cells compared with negative controls, 72 hours post-transfection. Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) was used as loading control.
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defined consisting of 16 differentially expressed miRNAs
potentially involved in the pigmentation process. Genetic
evidence that specific miRNA genes add an additional layer
of regulation during the pigmentation process is provided. In
particular, we focused on miR-145, which showed a marked
15-fold downregulation in mouse melanocytes treated with
ssUV and forskolin. Overexpression of miR-145 reduces the
expression of pigmentation genes (Tyr, Myo5a, Rab27a, and
Fscn1), and this correlates with decreased protein levels of
Tyr, Myo5a, Rab27a, and Fscn1 in melan-a cells. On the
other hand, downregulation of miR-145 resulted in an
increased gene expression level of these pigmentation genes,
adding extra weight to the importance of miR-145 during the
pigmentation process.
Prediction data from TargetScan database for mouse
showed that miR-145 could target Myo5a on two potential
binding sites located at the proximal region of the 30UTR of
Myo5a, which are separated by 333 nucleotides. In this
study, we were able to demonstrate that miR-145 post-
transcriptionally represses the expression of murine Myo5a
by direct binding to the first of its 30-UTR-binding sites,
whereas the other demonstrated no significant binding.
Moreover, we additionally confirmed the direct binding of
miR-145 to the 30UTR of human MYO5A by luciferase
reporter assays. Parallel to the mouse, we were able to show
that the first binding site of MYO5A mediates the interaction
between miR-145 and MYOVA 30UTR. Several research
groups, including ours, showed that Myo5a forms a tripartite
complex together with Rab27a and Mlph, responsible for
transporting melanosomes along actin filaments (Hume et al.,
2002; Wu et al., 2002; Westbroek et al., 2003). Disruption of
this tripartite complex, by loss or reduced expression of one
of the three members, results in a redistribution of melano-
somes from the peripheral to the perinuclear region. This
phenomenon is also observed in the melanocytes of GS
patients, which are characterized by hypopigmentation of the
skin and hair (Van Gele et al., 2009). Interestingly, we
observed a similar biological effect by introducing miR-145
into mouse melanocytes. This additionally confirms the direct
binding of miR-145 to Myo5a in mouse melanocytes. The
fact that the protein expression level of Rab27a was also
decreased may indicate that the overall stability of the
Rab27a–Mlph–Myo5a protein tripartite complex is affected.
Previously, similar effects have been observed after knocking
down MYO5A in human primary melanocytes by use of
siRNA (Van Gele et al., 2008). In this study, we also
overexpressed miR-145 in primary human melanocytes and
found that the same set of genes, as studied in mouse pigment
cells, were also decreased. In addition, overexpression of
miR-145 resulted in a clear accumulation/retention of
melanosomes around the nucleus, and we were able to
distinguish a clear hypopigmentation effect on cell pellets
from miR-145-transfected melanocytes compared with non-
treated controls. The observed hypopigmentation effect is
comparable to silencing of TYR and appears not solely to
be caused by the downregulation of MYO5A by miR-145,
followed by aberrant melanosome transport, but has an
additive effect by regulating several other key melanogenic
genes during the pigmentary process.
Here we found a downregulation of mRNA expression
level of Fscn1; however, this was less clear at the protein
level. To achieve efficient melanosome transport and transfer,
an intact subcortical actin network is mandatory. Fscn1 is a
key actin cross-linker, providing stiffness to filopodial bundles
(Vignjevic et al., 2003, 2006). Malfunction might hinder
effective melanosome capturing in melanocytic dendrites,
even though in miR-145-overexpressing melanocytes the
actin structure seemed intact with the resolution we used.
Future research is needed to establish the exact role of FSCN1
in the observed decreased pigmentation after miR-145
transfection.
Besides targeting genes located at the periphery of the
melanocyte that are responsible for correct transfer of
melanosomes, our results also indicate that miR-145 inter-
feres with transcription factors responsible for the initiation of
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Figure 3. miR-145 regulates Myo5a expression by targeting the 30-
untranslated region (30UTR) of Myo5a messenger RNA. (a) Relative 30-UTR
luciferase reporter activity for murineMyo5a. The luciferase activity ofMyo5a
is significantly decreased in the presence of the miR-145 and the reporter
construct containing the first predicted binding site of theMyo5a 30UTR (wild-
type (WT) experiment) as compared with transfection with a negative control
(NC) pre-miR. The reporter gene activity is rescued when using a scrambled
miRNA-binding site (Scr). *Po0.05. (b) Relative 30-UTR luciferase reporter
activity for human MYO5A. The luciferase activity of the MYO5A WT
construct (containing the three putative binding sites for miR-145 on the
30UTR of human MYO5A) decreases significantly in the presence of miR-145.
Mutagenesis of the first seed region (Mut1) resulted in a rescue effect,
indicating that seed 1 is the active binding site for miR-145. Mean levels
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transfected cells are depicted. P-values were determined by unpaired t-test.
*Po0.01.
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melanogenesis. Interestingly, it has been proposed that co-
regulation of miRNAs and transcription factors is of particular
importance in pigment pathways (Chen et al., 2011). SOX
(SRY-type high-mobility group box) proteins are transcription
factors that belong to the high-mobility group box super-
family of DNA-binding proteins and have a key role during
melanocyte development (Harris et al., 2010). SOX9 belongs
to the SOX-E subgroup, which includes SOX8, SOX9, and
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SOX10. The structures of these proteins show a high
conservation and similar positions of their high-mobility
group boxes. Passeron et al. (2007) identified cAMP-induced
upregulation of SOX9 as a main factor in the differentiation
and pigmentation of melanocytes after UVB exposure. SOX9
induces melanogenesis by regulating MITF, dopachrome
tautomerase, and TYR promoters. By binding directly to the
30-UTR region of SOX9, miR-145 may directly regulate the
influence of SOX9 on these pigmentary processes. Direct
binding of miR-145 to SOX9 was recently demonstrated for
mouse mesenchymal stem cells (Yang et al., 2011). Future
research will be necessary to address this in pigment cells.
Computational analysis by TargetScan also predicts three
potential binding regions for SOX10. SOX10 has an essential
role in pigment cell development and function. A number
of miRNAs potentially bind to the 30UTR of SOX10. They
include miR-155, miR-221, and miR-222. Our miRNA
profiling results support the notion that these miRNAs are
downregulated during the experimental pigmentation setup,
thus enabling SOX10 expression.
The identification of key downstream targets of miR-145 is
crucial for understanding the molecular basis of its role in
pigmentation. To obtain a more complete overview of the key
downstream targets of miR-145, a whole genome–wide gene
expression analysis (microarray) should be performed on
samples that have been overexpressed or knocked down for
this specific miRNA. This could reveal additional regulatory
elements involved throughout the pigmentation pathway.
Compared with single-target knockdown achieved by siR-
NAs, miRNAs could provide significant advantages for
therapeutic intervention by regulating multiple genes in a
single pathway (Seto, 2010). The miRNA network is well
coordinated by multiple intracellular regulatory systems, and
is considered to be effective, specific, and safe. In contrast to
siRNAs, miRNAs are naturally occurring regulatory compo-
nents that are inherent to the melanocyte machinery. By
targeting several genes in a more moderate way compared
with siRNAs, miRNAs may enhance the efficacy while
decreasing side effects resulting from aggressive single-gene
knockdown. As a result, miRNAs may be more suited for
therapeutic intervention. However, owing to their pleiotropic
effect, a careful mapping of the target genes of the considered
therapeutic miRNA is necessary to avoid dysregulation of
other pathways resulting in adverse effects.
In conclusion, this study has established, to our knowl-
edge, a previously unreported miRNA signature (16 miRNAs)
associated with ssUV and forskolin treatment. Significant
down- and upregulation of Myo5a expression, after modula-
tion of miR-145, is provided. In addition, miR-145 has the
ability to regulate other major pigmentation genes, suggesting
a key role for miR-145 in the transport of melanosomes and
the regulation of melanogenesis. We conclude that miR-145
could possibly be a potential therapeutic target in the
treatment of skin pigmentation disorders.
MATERIALS AND METHODS
Cell culture and treatment of cells with ssUV and forskolin
Murine melan-a melanocytes (from black mice) were kindly
provided by Dorothy Bennett (St George Hospital Medical School,
London, UK) and cultured in RPMI 1640 medium (Life Technologies
Europe B.V., Ghent, Belgium) supplemented with 10% fetal calf
serum, 2mM L-glutamine, streptomycin (50 mgml1), penicillin
(50Uml1), and 200 nM 12-O-tetradecanoylphorbol-13-acetate.
Before initiating and during the experimental setup, 12-O-tetra-
decanoylphorbol-13-acetate was removed from the culture medium.
After 48 hours, melan-a cells seeded at a density of 170,000 cells per
60mm (P60) dish were irradiated with ssUV, followed by addition of
20 mM forskolin, following a time-dependent treatment protocol.
Shortly before irradiation, the melan-a medium was removed and
replaced by a thin layer of phosphate-buffered saline. After removing
the plastic cover of the Petri dish, irradiation was administered using
an Oriel solar simulator (Model 91294-1000, Newport, Stratford,
CT). Using a UVB probe (SED 240), a dosage of 60 mJ cm2 was
measured with a research radiometer (IL1700; International Light,
Newburyport, MA). After irradiation, phosphate-buffered saline was
replaced by fresh RPMI 1640 medium containing 20 mM forskolin on
the UV-treated cells. Control melan-a cells were treated identically
without the irradiation and addition of forskolin. The time-dependent
treatment protocol was initiated 2 days after seeding, applying the
first treatment, followed by a second treatment 48 hours later, and a
third and final treatment after 24 hours. The cells were finally harve-
sted for miRNA extraction 24 hours after the last treatment. The cells
were incubated at a temperature of 37 1C, 99% humidity, and 10%
CO2. Human primary epidermal melanocyte cultures were established
as described previously (Naeyaert et al., 1991; Van Gele et al., 2008).
RNA isolation and RT-qPCR
Total RNA, including miRNAs, was extracted from melan-a cells
using the miRNeasy Mini kit (Qiagen, Venlo, The Netherlands)
according to the manufacturer’s recommendations. A DNase
treatment was performed and first-strand cDNA was generated by
reverse transcription using the iScript cDNA synthesis kit according
to the manufacturer’s instructions (Bio-Rad, Eke, Belgium). Relative
gene expression levels were determined using a SYBR Green I
reverse transcription-PCR assay as described by Vandesompele et al.
(2002a), and the comparative Cq method was used for quantification.
Figure 4. Overexpression of miR-145 induces perinuclear aggregation of melanosomes and reduced pigmentation. The melanosomal marker HMB45 (green)
and Myo5a (red) colocalize and accumulate around the nucleus of pre-miR-145-transfected melan-a cells, whereas both markers show a peripheral staining in
control-transfected cells (a, left panel). In addition, fixed melan-a cells were stained with HMB45 and phalloidin. A normal melanosome distribution is observed
in control cells compared with a perinuclear accumulation in the pre-miR-145-transfected melan-a cells (a, right panel). The actin cytoskeleton is intact. Nuclei
were counterstained in blue with 46-diamidino-2-phenyl indole. (b) Overexpression of miR-145 in human primary melanocytes results in a perinuclear
accumulation of melanosomes (stained with the melanosomal marker NKI-beteb), whereas a normal melanosomal distribution is present in the control-
transfected cells. Bar ¼ 20mm. (c) Harvested pellets of pre-miR-145-transfected primary human melanocytes displaying a hypopigmented phenotype
comparable to small interfering RNA (siRNA) tyrosinase–transfected melanocytes. Intensities of the pellets were measured with Fiji software, and the mean
values of the two controls were rescaled to 1 and compared against the treated conditions (n¼3 measurements ±SEM).
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PCR reactions were performed using SYBR Green I master mix
(Eurogentec, Ougre´e Seraing, Belgium) and were run on a MyiQ
iCycler (Bio-Rad). To correct for differences in RNA quantities and
cDNA synthesis efficiency, relative gene expression levels were
normalized using the geometric mean of three reference genes
(RPL13A, UBC, and SDHA) according to Vandesompele et al.
(2002b).
miRNA profiling
For miRNA cDNA synthesis, RNA was reverse transcribed using the
miRNA reverse transcription kit in combination with the murine
stem-loop Megaplex primer pools A and B (Life Technologies Europe
B.V.), allowing simultaneous reverse transcription of a total of 540
miRNAs and endogenous controls. Briefly, 10 ng of total RNA was
supplemented with RT primer mix (10 ), RT buffer (10 ),
MultiScribe Reverse Transcriptase (50Uml1), dNTPs with dTTP
(100mM each), MgCl2 (25mM), and RNase inhibitor (20U ml
1) in a
total reaction volume of 8ml. To increase reverse transcription
efficiency, a pulsed RT reaction was used (40 cycles of 16 1C for
2 minutes, 42 1C for 1 minute, and 50 1C for 1 second, followed by
a final reverse transcriptase inactivation at 85 1C for 5 minutes).
For each cDNA sample, a total of 540 miRNAs and endogenous
controls were profiled using a gene maximization PCR plate setup in
a 384-well plate. The RT product was diluted 400-fold. PCR
amplification reactions were carried out in a total volume of 8ml,
containing 4ml of TaqMan Master mix, 1ml of cDNA, and 3ml of
miRNA TaqMan probe and primers (Life Technologies Europe B.V.).
Cycling conditions were as follows: 95 1C for 10 minutes
followed by 40 cycles of 95 1C for 15 seconds and 60 1C for
1minute. All PCR reactions were performed on the 7900HT
RT-qPCR system (Applied Biosystems, Halle, Belgium). Raw Cq
values were calculated using the SDS software v.2.1 (Applied
Biosystems) using automatic baseline settings and a threshold of 0.2.
miRNA expression data were normalized using the global mean
(Mestdagh et al., 2009).
Luciferase reporter assay for murine myosin Va
Dicer-deficient (DLD-1 Dicerex5) cells were seeded in DMEM (Life
Technologies Europe B.V.), supplemented with fetal calf serum
(10%) at a density of 10,000 cells per well in an opaque 96-well
plate (Cummins et al., 2006). Twenty-four hours after seeding, using
DharmaFECT Duo (Dharmacon, Thermo Scientific, Erembodegem,
Belgium), cells were transfected with 100 ng of a psiCHECK-2
reporter construct (Promega Benelux B.V., Leiden, The Netherlands),
either alone or together with a miR-145 mimic or a negative control
miRNA (Life Technologies Europe B.V.). Reporter constructs con-
tained one of the two miRNA-binding sites present in the 30UTR of
Myo5a cloned downstream of the Renilla luciferase gene (see also
Supplementary Table S2 online). Forty-eight hours after transfection,
luciferase assay reporter gene activity was measured using the Dual-
Luciferase Reporter assay system (Promega Benelux B.V.) and a
FLUOstar OPTIMA microplate reader (BMG LABTECH GmbH,
Ortenberg, Germany). Renilla luciferase activities were normalized
against Firefly luciferase activities.
Additional information regarding the luciferase assay for human
myosin VA, pre-miR/anti-miR transfections, miRNA quantification,
western blotting, immunohistochemistry, and quantification of cell
pellets is available in the Supplementary Materials and Methods online.
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